Press-release for stocks related to covid-19 for edsa

Prices are updated after-hours

Edesa Biotech Receives Canadian Approval to Test COVID-19 Drug as Rescue Therapy
Published: 2022-01-13 (Crawled : 13:30) - biospace.com/
EDSA | $4.47 2.52% 2.46% 2.4K

| -22.42% | O: 6.49% H: 0.0% C: -13.11%
covid-19 drug approval covid test therapy biotech iot

Edesa Biotech Extends COVID-19 Clinical Study to Poland
Published: 2021-11-04 (Crawled : 12:15) - biospace.com/
EDSA | $4.47 2.52% 2.46% 2.4K

| -50.4% | O: -1.25% H: 0.0% C: -1.61%
covid biotech iot covid-19

Edesa Biotech Reports Favorable Mortality Reductions in COVID-19 Study
Published: 2021-10-19 (Crawled : 12:15) - biospace.com/
EDSA | $4.47 2.52% 2.46% 2.4K

| -43.67% | O: 13.82% H: 0.45% C: -6.7%
covid biotech iot eb05 covid-19

Edesa Biotech Announces Positive Phase 2 Data of Its Monoclonal Antibody in Hospitalized COVID-19 Patients
Published: 2021-09-20 (Crawled : 12:15) - biospace.com/
EDSA | $4.47 2.52% 2.46% 2.4K

| -22.21% | O: 68.6% H: 26.98% C: 26.14%
covid phase 2 positive antibody biotech iot covid-19

Edesa Biotech Enrolls More Than 525 COVID-19 Patients Ahead of Schedule
Published: 2021-08-26 (Crawled : 12:00) - biospace.com/
EDSA | $4.47 2.52% 2.46% 2.4K

| -6.84% | O: 4.7% H: 3.06% C: 0.61%
covid biotech iot enroll covid-19

Edesa Biotech Reports Favorable Review of COVID-19 Study
Published: 2021-06-18 (Crawled : 12:15) - biospace.com/
EDSA | $4.47 2.52% 2.46% 2.4K

| -23.51% | O: 8.25% H: 2.96% C: -9.56%
covid biotech iot covid-19

Edesa Biotech Receives C$14 million for COVID-19 Study
Published: 2021-02-02 (Crawled : 19:00) - biospace.com/
EDSA | $4.47 2.52% 2.46% 2.4K

| -29.68% | O: -0.32% H: 31.88% C: -2.91%
covid biotech covid-19

Edesa Biotech to Join Panel Discussion at Government COVID-19 Event
Published: 2021-01-20 (Crawled : 16:00) - biospace.com/
EDSA | $4.47 2.52% 2.46% 2.4K